Skip to main content
All lobbying filings

W STRATEGIES, LLC

Lobbying for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS · A clinical-stage biopharmaceutical company.

 Filing 4th Quarter - Termination
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · $50,000.00 income · posted Jan 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Education and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem